Safety of zoledronic acid and incidence of osteonecrosis of the jaw (ONJ) during adjuvant therapy in a randomised phase III trial (AZURE: BIG 01–04) for women with stage II/III breast cancer
Titel:
Safety of zoledronic acid and incidence of osteonecrosis of the jaw (ONJ) during adjuvant therapy in a randomised phase III trial (AZURE: BIG 01–04) for women with stage II/III breast cancer
Auteur:
Coleman, R. Woodward, E. Brown, J. Cameron, D. Bell, R. Dodwell, D. Keane, M. Gil, M. Davies, C. Burkinshaw, R. Houston, S. J. Grieve, R. J. Barrett-Lee, P. J. Thorpe, H.